Registry monitoring long-term performance of ICD leads
Official title: LUKS-Leads Registry on Long-term Performance of ICD Leads
Run by Luzerner Kantonsspital · NCT03521050 · Data updated 2026-11-12
This study looks at how well the wires in implantable heart devices work over time for patients who got these devices at the Cantonal Hospital Lucerne since 2006.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Luzerner Kantonsspital Academic / other |
| Locations | 1 site (Lucerne) |
| Status | Recruiting |
| Started | December 2016 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | September 4, 2020 |
| Trial ID | NCT03521050 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include all patients who have received an ICD lead at the Cantonal Hospital Lucerne since 2006.
✕Probably not a fit
Patients who refuse data collection for scientific purposes will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry collects data on patients who have received an implantable cardiac defibrillator (ICD) at the Cantonal Hospital Lucerne since 2006. The study aims to evaluate the long-term performance of ICD leads, particularly in light of early failures observed in certain leads. Data is collected prospectively from December 2016 onwards, focusing on parameters such as electronic impedances, threshold values, sensing values, battery performance, and shock release effectiveness during regular clinical evaluations.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding of ICD lead performance and improve patient outcomes by identifying leads that may fail early.
How similar studies have gone: Other studies have shown success in monitoring device performance, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients being implanted with a Defibrillator lead from 2006 onwards Exclusion Criteria: * documented refusal of data collection for scientific purposes
Where it's running
-
Luzerner Heart Centre
Lucerne, Switzerland Recruiting
Study contacts
- Principal investigator: Richard Kobza, MD — Luzerner Kantonsspital
- Study coordinator: Richard Kobza, MD
- Email: richard.kobza@luks.ch
- Phone: +41412055144
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Impact of wireless monitoring on heart failure patients
This study tests if using wireless monitoring can help heart failure patients with pacemakers and defibrillators stay healthier and reduce unexpected hospital visits.
-
Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care
This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.
-
Using slew rate to predict lead performance in pacemakers and defibrillators
This study is testing if measuring the electrical signals during the placement of pacemakers and defibrillators can help predict how well the devices will work over time.
-
Observational study on a new type of implantable defibrillator
This study looks at a new type of implantable defibrillator to see how well it works in preventing sudden cardiac death in patients who are at high risk.
-
Registry for extracting pacemaker and ICD leads
This study is collecting information from patients who need their pacemaker or ICD leads removed to see how the procedure goes and to make it safer for everyone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.